Taking a company as experimental as SpaceX public at a $135 price point introduces significant risks that could clash with the company's culture of rapid, iterative failure. Public markets typically demand consistent quarterly growth and predictable outcomes, which are often at odds with the nature of rocket development. The pressure to satisfy shareholders could force management to become more risk-averse, potentially slowing down the very innovation that made the company successful in the first place.
Critics point out that the valuation is heavily predicated on the future success of Starship, a vehicle that is still in the testing phase. If the upcoming launch encounters significant issues, the resulting stock volatility could create a distraction for engineers and leadership. In a private setting, SpaceX could absorb these setbacks without the immediate scrutiny of the public market, but as a public entity, every test failure will now be translated into a potential loss of market capitalization.
There is also the concern of transparency requirements. While public companies must disclose information, the competitive nature of the aerospace industry means that revealing too much could provide rivals with strategic advantages. Balancing the need for shareholder communication with the need to protect proprietary technology and trade secrets will be a difficult challenge for the company. Investors may find that the reality of public reporting does not align with the high-speed, opaque environment they have come to expect from the firm.
Finally, the $135 price may be seen by some as an aggressive valuation that leaves little room for error. If the company fails to meet the high expectations set by this IPO, the resulting market correction could damage its ability to raise future capital. For a company that requires massive, continuous investment to achieve its goals, any loss of market confidence could have real-world consequences for its ability to continue its mission-critical work.